15 June 2020

• FDA revokes its EUA for chloroquine and hydroxychloroquine, saying “…it is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19, nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risks.” Source
• FDA warns of a using chloroquine or hydroxychloroquine and remdesivir together, due to a drug interaction which may lower remdesivr’s effectiveness. Source

Return to the timeline